NATCO PHARMA LTD. - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended June 30, 2024 And Declaration Of Interim Dividend For FY 2024-25, If Any

NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 ,inter alia, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2024 and declaration of Interim Dividend for FY 2024-25, if any